Purple Style Labs Limited IPO Proceeds Monitoring Report
Purple Style Labs Ltd · Others (Uncategorized) · 11 Nov 2026, 12:05 am
Purple Style Labs Limited IPO Proceeds Monitoring Report CARE Ratings issued the Q2FY27 monitoring agency report for Purple Style Labs' ₹680.00 crore IPO proceeds, confirming no deviation from stated objects. Out of total proceeds, the company utilized ₹140.74 crore, including ₹84.40 crore for General Corporate Purposes (primarily subsidiary debt repayment), ₹54.44 crore for issue expenses, and ₹1.90 crore for sales and marketing, leaving ₹539.26 crore unutilized mostly in fixed deposits. Key monitorables include ongoing financial stress, a trademark license dispute notice from Pernia Qureshi, and a ₹0.71 crore GST liability reconciliation requirement.
Original exchange filing (PDF)
More announcements from Purple Style Labs Ltd
- Link for Audio Recording of the Earnings Conference Call on the financial results for the quarter and half year ended September 30, 2026 held on November 03, 2026. · 03 Nov 2026
- Investor Presentation on the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Purple Style Labs Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026. · 02 Nov 2026
- Unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026 · 02 Nov 2026
- Unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026 · 02 Nov 2026
- Intimation of Schedule of Earnings Conference Call on financial results for the quarter and half year ended September 30, 2026. · 03 Nov 2026
- PURPLE STYLE LABS LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 02 Nov 2026
- To consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026 · 02 Nov 2026
